Acadia Pharmaceuticals (ACAD) Change in Cash (2010 - 2026)

Acadia Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at $104.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 202.58% year-over-year to $104.5 million; the TTM figure through Mar 2026 stood at $63.6 million (up 298.67% YoY), while the FY2025 annual figure was -$142.8 million, down 206.64% from the prior year.
• Change in Cash for Q1 2026 stood at $104.5 million, up from -$81.9 million in the prior quarter.
• The five-year high for Change in Cash was $176.0 million in Q1 2023, with the low at -$180.6 million in Q2 2023.
• The 5-year median for Change in Cash is $4.4 million (2025), against an average of $8.1 million.
• The sharpest annual moves came in 2022 and 2025: Change in Cash surged 366.86% in 2022, then tumbled 733.35% in 2025.
• Acadia Pharmaceuticals' Change in Cash stood at -$40.0 million in 2022, then surged by 326.18% to $90.5 million in 2023, then jumped by 81.77% to $164.4 million in 2024, then tumbled by 149.82% to -$81.9 million in 2025, then surged by 227.57% to $104.5 million in 2026.
• Business Quant data shows ACAD's Change in Cash at $104.5 million in Q1 2026, -$81.9 million in Q4 2025, and $4.4 million in Q3 2025.